UBS raised the firm’s price target on Veeva (VEEV) to $285 from $250 and keeps a Neutral rating on the shares. Veeva had a solid beat and raise quarter, but “not +17% good,” the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva price target raised to $335 from $280 at BTIG
- Veeva price target raised to $295 from $272 at Stifel
- Veeva price target raised to $300 from $285 at Wells Fargo
- Veeva Systems’ Strong Q1 Performance and Raised Outlook Signal Promising Growth Amid CRM Transition Challenges
- Veeva price target raised to $325 from $255 at Piper Sandler